Double Bonded Protein Chocolate
En vente sur le marché américain (selon le DSLD)
Mt. Capra, food supplement from the US market
Double Bonded Protein Chocolate (Mt. Capra), a food supplement without a usable barcode in DSLD, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Mt. Capra
- Barcode
- Not provided or invalid in DSLD
- Form
- Powder
- One serving
- 33.5 g
- Servings
- up to 2 servings per day
- Other ingredients (in English, as written)
- Goat Milk Protein, Fermented Goat-Milk Protein, organic Cocoa powder, natural Chocolate flavor, Guar Gum, Xanthan Gum, Stevia
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Total Calories | Other | 124 kcal |
| Calories from Fat | Other | 9 kcal |
| Fat | Fat | 1 g |
| Saturated Fat | Fat | 0 g |
| Trans Fat | Fat | 0 g |
| Sodium | Mineral | 13 mg |
| Total Carbohydrates | Carbohydrate | 8 g |
| Dietary Fiber | Fibre | 1.3 g |
| Sugar | Carbohydrate | 0 g |
| Protein | Protein | 21 g |
| Calcium | Mineral | 319 mg |
| Amino Acid Profile | ||
| Asparagine | Amino acid | 2,230 mg |
| Threonine | Amino acid | 1,181 mg |
| Serine | Amino acid | 991 mg |
| Glutamate | Amino acid | 3,316 mg |
| Proline | Amino acid | 1,260 mg |
| Methionine | Amino acid | 428 mg |
| Valine | Amino acid | 1,221 mg |
| Alanine | Amino acid | 1,154 mg |
| Glycine | Amino acid | 491 mg |
| Isoleucine | Amino acid | 1,127 mg |
| Leucine | Amino acid | 2,526 mg |
| Tyrosine | Amino acid | 907 mg |
| Histidine | Amino acid | 440 mg |
| Lysine | Amino acid | 2,074 mg |
| Arginine | Amino acid | 732 mg |
| Tryptophan | Amino acid | 70 mg |
| Phenylalanine | Amino acid | 859 mg |
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Double Bonded Protein Chocolate
Entered into DSLD on 23 February 2012. En vente sur le marché américain (selon le DSLD).- Active ingredient removed : Methionine (428 mg)
- Different quantity per serving : Sugar: 3 g in this version; 0 g on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Tyrosine
Read the warning, when it applies and the studies cited
L-TYROSINE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
- Lysine
Read the warning, when it applies and the studies cited
LYSINE
Route of administration: Oral
Cautions and warnings
Applies to products providing more than 300 mg of lysine, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Goldman and Ausiello 2004).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
- Arginine
Read the warning, when it applies and the studies cited
L-ARGININE
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/ physician before use if you are pregnant or breastfeeding.
Condition of application: Improvement in exercise capacity in individuals with stable CVD.
Ask a health care practitioner/health care provider/health care professional/doctor/ physician if your symptoms worsen.
Applies to products providing more than 0.42 g of L-Arginine, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/ physician before use if you have a cardiovascular disease and are attempting an increase in physical activity (Doutreleau et al. 2010; Doutreleau et al. 2006; Schulman et al. 2006; Goldman and Ausiello 2004; Nagaya et al. 2001; Bednarz et al. 2000; Ceremużyński et al. 1997; Rector et al. 1996).
8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/ physician before use if you are taking medication for cardiovascular diseases, erectile dysfunction, and/or blood thinners (Huynh et al. 2002; Parker et al. 2002; Siani et al. 2000; Adams et al. 1995).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Applies to products providing more than 9 g of L-Arginine, per day.
Do not use if you have had a heart attack/myocardial infarction (Sun et al. 2009; Schulman et al. 2006; Bednarz et al. 2005).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Applies to products providing more than 9 g of L-Arginine, per day.
When using this product you may experience gastrointestinal discomfort/disturbances (Grimble 2007; Evans et al. 2004; IOM 2005; Clarkson et al. 1996).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Mt. Capra
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.